Planning for globally coordinated cessation of bivalent oral poliovirus vaccine: risks of non-synchronous cessation and unauthorized oral poliovirus vaccine use

Planning for globally coordinated cessation of bivalent oral poliovirus vaccine: risks of non-synchronous cessation and unauthorized oral poliovirus vaccine use

Abstract Background Oral polio vaccine (OPV) containing attenuated serotype 2 polioviruses was globally withdrawn in 2016, and bivalent OPV (bOPV) containing attenuated serotype 1 and 3 polioviruses needs to be withdrawn after the certification of eradication of all wild polioviruses to eliminate fu...

Full description

Bibliographic Details
Main Authors: Radboud J. Duintjer Tebbens, Lee M. Hampton, Kimberly M. Thompson
Format: Article
Language:English
Published: BMC 2018-04-01
Series:BMC Infectious Diseases
Subjects:
Polio
Eradication
Risk management
Oral poliovirus vaccine
Dynamic modeling
Vaccine-derived poliovirus
Online Access:http://link.springer.com/article/10.1186/s12879-018-3074-0

Internet

http://link.springer.com/article/10.1186/s12879-018-3074-0

Similar Items